JY
MRKR icon

Jeff Yass’s Marker Therapeutics MRKR Stock Holding History

Jeff Yass’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-48,780
Closed -$63.4K – 14122
2026
Q1 		$63.4K Buy
+48,780
New +$77.4K ﹤0.01% 12553
2025
Q3 		– Sell
-12,437
Closed -$19K – 13343
2025
Q2 		$19K Sell
12,437
-18,590
-60% -$23.9K ﹤0.01% 12343
2025
Q1 		$38.2K Buy
+31,027
New +$56.8K ﹤0.01% 11945
2024
Q2 		– Sell
-14,817
Closed -$63.7K – 12807
2024
Q1 		$63.7K Buy
+14,817
New +$64.7K ﹤0.01% 11457
2023
Q2 		– Sell
-17,606
Closed -$12.5K – 12744
2023
Q1 		$12.5K Buy
+17,606
New +$41.9K ﹤0.01% 12161
2022
Q4 		– Sell
-1,480
Closed -$5K – 13213
2022
Q3 		$5K Buy
+1,480
New +$5.43K ﹤0.01% 12883
2022
Q2 		– Sell
-17,154
Closed -$57.1K – 13565
2022
Q1 		$76K Sell
17,154
-21,026
-55% -$120K ﹤0.01% 12083
2021
Q4 		$363K Buy
38,180
+15,242
+66% +$202K ﹤0.01% 10024
2021
Q3 		$388K Buy
22,938
+18,176
+382% +$372K ﹤0.01% 10006
2021
Q2 		$133K Buy
4,762
+419
+10% +$11K ﹤0.01% 11926
2021
Q1 		$97K Buy
4,343
+3,250
+297% +$74.4K ﹤0.01% 11876
2020
Q4 		$16K Buy
+1,093
New +$17K ﹤0.01% 10898
2020
Q3 		– Sell
-1,884
Closed -$34.4K – 10923
2020
Q2 		$39K Sell
1,884
-590
-24% -$12.9K ﹤0.01% 9811
2020
Q1 		$47K Sell
2,474
-3,437
-58% -$87.6K ﹤0.01% 9708
2019
Q4 		$170K Buy
5,911
+598
+11% +$21.8K ﹤0.01% 8873
2019
Q3 		$271K Sell
5,313
-801
-13% -$47.3K ﹤0.01% 8522
2019
Q2 		$484K Sell
6,114
-1,542
-20% -$91.6K ﹤0.01% 7333
2019
Q1 		$505K Buy
7,656
+5,610
+274% +$328K ﹤0.01% 6253
2018
Q4 		$114K Buy
+2,046
New +$149K ﹤0.01% 8156

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Jeff Yass's MRKR Position: Q2 2026 in Review

Jeff Yass sold out of Marker Therapeutics (MRKR) in Q2 2026, closing a stake of 48,780 shares — an estimated $63.4K sold.

Jeff Yass first reported a position in MRKR in Q4 2018 and held it in 19 quarters. The position peaked at $505K in Q1 2019. 35 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

  • Jeff Yass reported no remaining Marker Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 48,780 Marker Therapeutics shares in Q2 2026, an estimated $63.4K.
  • Jeff Yass first reported a position in Marker Therapeutics in Q4 2018 and held it in 19 quarters.
  • Jeff Yass's Marker Therapeutics position peaked at $505K in Q1 2019.
  • 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.